BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2125755)

  • 1. Clinical significance of various ELISA assays for detecting antiphospholipid antibodies.
    Falcón CR; Hoffer AM; Forastiero RR; Carreras LO
    Thromb Haemost; 1990 Aug; 64(1):21-5. PubMed ID: 2125755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of lupus-like anticoagulants by an enzyme-linked immunosorbent assay using a partial thromboplastin as antigen; a comparative study.
    Arnout J; Huybrechts E; Vanrusselt M; Falcon C; Vermylen J
    Thromb Haemost; 1990 Aug; 64(1):26-31. PubMed ID: 2125756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times.
    Alving BM; Barr CF; Tang DB
    Am J Med; 1990 Feb; 88(2):112-6. PubMed ID: 2105643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies.
    Galli M; Beretta G; Daldossi M; Bevers EM; Barbui T
    Thromb Haemost; 1997 Mar; 77(3):486-91. PubMed ID: 9065999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of various screening and confirmatory tests for the detection of the lupus anticoagulant.
    Forastiero RR; Falcón CR; Carreras LO
    Haemostasis; 1990; 20(4):208-14. PubMed ID: 2122955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the relationship between 'antiphospholipid' antibodies and the lupus anticoagulant.
    Exner T; McRea J
    Blood Coagul Fibrinolysis; 1990; 1(1):17-21. PubMed ID: 2129389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative sensitivity of different tests in the detection of low titer lupus anticoagulants.
    Lesperance B; David M; Rauch J; Infante-Rivard C; Rivard GE
    Thromb Haemost; 1988 Oct; 60(2):217-9. PubMed ID: 3146139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinguishing plasma lupus anticoagulants from anti-factor antibodies using hexagonal (II) phase phospholipids.
    Rauch J; Tannenbaum M; Janoff AS
    Thromb Haemost; 1989 Nov; 62(3):892-6. PubMed ID: 2512678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dilute phospholipid APTT: a sensitive assay for verification of lupus anticoagulants.
    Alving BM; Baldwin PE; Richards RL; Jackson BJ
    Thromb Haemost; 1985 Oct; 54(3):709-12. PubMed ID: 3937268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between a one-point dilute phospholipid APTT and the dilute Russell viper venom time for verification of lupus anticoagulants.
    Alving BM; Barr CF; Johansen LE; Tang DB
    Thromb Haemost; 1992 Jun; 67(6):672-8. PubMed ID: 1509408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid antibodies and recurrent pregnancy loss: correlation between the activated partial thromboplastin time and antibodies against phosphatidylserine and cardiolipin.
    Rote NS; Dostal-Johnson D; Branch DW
    Am J Obstet Gynecol; 1990 Aug; 163(2):575-84. PubMed ID: 2117391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME; Cabiedes J; Reyes E; Cabral AR
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of procoagulant phospholipid interfering in tests for lupus anticoagulant.
    Exner T; Low J
    Thromb Res; 2004; 114(5-6):547-52. PubMed ID: 15507290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticardiolipin antibodies: their presence as a marker for lupus anticoagulant in pregnancy.
    Pattison NS; McKay EJ; Liggins GC; Lubbe WF
    N Z Med J; 1987 Feb; 100(817):61-4. PubMed ID: 3103033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal hybridoma anti-cardiolipin antibodies from SLE mice.
    Ichikawa K; Shimada K; Nawata Y; Ishii T; Tomioka H; Yoshida S; Koike T
    Clin Exp Immunol; 1988 Oct; 74(1):110-4. PubMed ID: 3146452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of anticardiolipin antibodies by cultured human lymphocytes.
    Smith HR; Hansen CL; Canoso RT
    J Clin Lab Immunol; 1990 May; 32(1):1-4. PubMed ID: 1967031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protean clinical presentation of antiphospholipid-protein antibodies (APA).
    Triplett DA
    Thromb Haemost; 1995 Jul; 74(1):329-37. PubMed ID: 8578480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
    Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
    Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of antiphospholipid antibodies by ELISA-method with bovine thromboplastin as antigen.
    López-Soto A; Casals FJ; Font J; Cervera R; Ingelmo M
    Thromb Res; 1989 Mar; 53(6):623-8. PubMed ID: 2499948
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.